Skip to main content

Closed

CGEM: Cullinan Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-65.2%

Financially safe

Stretched

Debt / equity0.01×

Interest coverage0.0×

Current ratio10.28×

Cullinan Therapeutics, Inc.

CGEMNASDAQ Global Select·USD·Closed

Cullinan Therapeutics, Inc.

CGEMNASDAQ·USD·Closed

$16.50

−5.82%

$16.50

−$1.02 (5.82%)

52W Range

79thpctl

Volume

0.80×avg

Mkt Cap

1.01BUSD

P/E

-4.4TTM

Div Yield

–ann

52W Range

79thpctl

Volume

0.80×avg

Market Cap

1.01BUSD

P/E Ratio

-4.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings